Imaging Agents

Imaging Agents

Global Imaging Agents Market to Reach US$13.4 Billion by 2030

The global market for Imaging Agents estimated at US$9.8 Billion in the year 2023, is expected to reach US$13.4 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Diagnostic Radiopharmaceuticals, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$7.2 Billion by the end of the analysis period. Growth in the X-Ray / CT segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.7 Billion While China is Forecast to Grow at 7.9% CAGR

The Imaging Agents market in the U.S. is estimated at US$2.7 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 7.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.0% CAGR.

Global Imaging Agents Market - Key Trends and Drivers Summarized

Diagnostic imaging agents, or contrast agents, are substances administered to patients to enhance the imaging process for disease diagnosis. These agents help radiopharmaceuticals emit energy using various methods, such as X-rays, gamma rays, sound waves, radio waves (MRI), and radioactive particles. By improving image contrast, they enable healthcare professionals to better visualize and assess body structures and detect abnormalities, providing critical insights for accurate diagnosis. Medical imaging is a critical tool that saves millions of lives by helping doctors diagnose diseases ranging from cancer to stroke. One of the most influential trends shaping this field is artificial intelligence (AI).

Technological progress in medical imaging continues to expand possibilities, leading to faster, safer, and more efficient imaging. Companies leverage advanced technology and globally accepted safety protocols to offer comprehensive imaging solutions. Key drivers in imaging advancements include AI, machine learning, and deep learning. These technologies are integrated into CT scans, MRIs, and ultrasounds to automate repetitive tasks with nearly perfect accuracy, cutting costs compared to traditional methods. Healthcare professionals increasingly rely on AI-based solutions to assess risk and tailor treatments, ensuring optimal, cost-effective therapy. Virtual and augmented reality (VR/AR) in 3D medical imaging technologies provide physicians with enhanced visualization of complex structures by creating 3D images from 2D MRI or CT scans. While the VR/AR market is still developing, its transformative potential in healthcare is becoming evident.

Nuclear imaging and wearable technology are also driving advancements in medical imaging. Nuclear imaging uses radiotracers to provide detailed insights into internal conditions such as cancer and Alzheimer`s disease, with devices like the EXPLORER Total-body PET/CT Scanner improving efficiency. Wearables offer new applications in radiology, with the HD-DOT instrument and wearable ultrasound scanners enabling continuous brain and organ monitoring. These innovations are expanding diagnostic capabilities and improving patient care by providing earlier detection and more effective treatments.

Select Competitors (Total 23 Featured) -

• Aytu BioScience Inc.
• Bayer Healthcare Pharmaceuticals
• Bracco Diagnostics Inc.
• Curium
• Daiichi Sankyo Company Limited
• Eli Lilly
• GE Healthcare
• Guerbet Group
• Lantheus Medical Imaging Inc.
• Piramal Imaging SA

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.